Format

Send to:

Choose Destination
  • Showing results for current preclinical models for the advancement of translational bladder cancer research. Your search for Current pre-clinical models for the advancement of translational bladder cancer research retrieved no results.
See comment in PubMed Commons below
Mol Cancer Ther. 2013 Feb;12(2):121-30. doi: 10.1158/1535-7163.MCT-12-0508. Epub 2012 Dec 26.

Current preclinical models for the advancement of translational bladder cancer research.

Author information

  • 11Vanderbilt University Medical Center, Nashville,Tennessee, USA.

Abstract

Bladder cancer is a common disease representing the fifth most diagnosed solid tumor in the United States. Despite this, advances in our understanding of the molecular etiology and treatment of bladder cancer have been relatively lacking. This is especially apparent when recent advances in other cancers, such as breast and prostate, are taken into consideration. The field of bladder cancer research is ready and poised for a series of paradigm-shifting discoveries that will greatly impact the way this disease is clinically managed. Future preclinical discoveries with translational potential will require investigators to take full advantage of recent advances in molecular and animal modeling methodologies. We present an overview of current preclinical models and their potential roles in advancing our understanding of this deadly disease and for advancing care.

©2012 AACR.

PMID:
23269072
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk